Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Net Loans Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Fortress Biotech (FBIO) Change in Intangibles (2016 - 2024)

Fortress Biotech has reported Change in Intangibles over the past 7 years, most recently at $15.0 million for Q4 2024.

Quarterly results put Change in Intangibles at $15.0 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was -$5.0 million (up 75.0% YoY), and the annual figure for FY2024 was $15.0 million, up 200.0%.
Change in Intangibles for Q4 2024 was $15.0 million at Fortress Biotech, up from -$20.0 million in the prior quarter.
Over the last five years, Change in Intangibles for FBIO hit a ceiling of $15.0 million in Q4 2024 and a floor of -$20.0 million in Q4 2022.
Median Change in Intangibles over the past 3 years was $600000.0 (2020), compared with a mean of -$633333.3.